Overview
What It Solves
Assessing new healthcare technologies requires combining clinical outcomes, economic value, and regulatory considerations — a process that is often manual, time-consuming, and inconsistent.
Overview
How It Works
Balin applies AI and structured data intelligence to the HTA evaluation process, organizing assessment data into a unified framework. Machine learning models enable consistent, evidence-based evaluation through standardized workflows supported by predictive benchmarking.
Previous
Next
Key Functional Areas
Health Technology Assessment (HTA) evaluates the clinical effectiveness, cost-efficiency, and broader impact of health technologies.
NLP and ML models extract, structure, and analyze clinical effectiveness and cost data from diverse evidence sources, supporting balanced decisions.
AI compares technologies across markets, therapeutic areas, and competitors to deliver contextualized insights with forecast confidence scores.
Predefined evaluation processes include AI-assisted decision checkpoints that surface relevant evidence and flag assessment gaps in real time.
ML models monitor preparedness for regulatory submissions, predicting timelines and alerting teams to potential compliance gaps.
Generative AI produces structured, data-backed assessment reports for stakeholders, dramatically reducing manual documentation effort.
Previous
Next
Operational Impact
Organizations accelerate evaluation timelines, improve consistency in decision-making, and ensure stronger regulatory alignment with AI-supported evidence management.